| Pharmaceutical active ingredients: |
| Triamcinolone Acetonide |
| Available forms, composition and doses of Nasacort HFA: |
| Spray, Metered-Dose; Nasal; Triamcinolone Acetonide 0.055 mg / dose |
| Nasacort HFA medical category: |
| Human:AdrenalsAnti-inflammatory agentsCorticosteroid hormonesMouth / throat preparationsNasal decongestants and other nasal preparationsTopical corticosteroidsTopical corticosteroids used as nasal decongestants |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A01AC01 - TriamcinoloneC05AA12 - TriamcinoloneD07AB09 - TriamcinoloneD07XB02 - TriamcinoloneH02AB08 - TriamcinoloneR01AD11 - TriamcinoloneR03BA06 - TriamcinoloneS01BA05 - Triamcinolone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Related documents and information about Nasacort HFA: |
| Nasacort prescribing information (PDF)Nasacort AQ prescribing information (PDF)Nasacort HFA prescribing information (PDF) |